Radionuclide Imaging of Hepatic and Biliary Disease

Eugene C. Lin; Christopher C. Kuni

doi:10.1055/s-2001-15495

Seminars in Liver Disease, Inhaltsverzeichnis

Semin Liver Dis 2001; 21(2): 179-194
DOI: 10.1055/s-2001-15495

Radionuclide Imaging of Hepatic and Biliary Disease

Eugene C. Lin, Christopher C. Kuni

Department of Radiology, University of Colorado Health Sciences Center, Denver, Colorado

Abstract

ABSTRACT

This article will focus on common clinical applications of scintigraphy in focal hepatic lesions, acute cholecystitis, biliary dyskinesia, biliary obstruction, postoperative liver and biliary tract, and neonatal cholestasis. The utility of positron emission tomography will also be addressed.

KEYWORD

Biliary tract - liver - positron emission tomography - radionuclide imaging - scintigraphy

Volltext

Referenzen

REFERENCES

1 Krishnamurthy G, Krishnamurthy S. Imaging agents. In: Krishnamurthy G, Krishnamurthy, S, eds. Nuclear Hepatology: A Textbook of Hepatobiliary Diseases Berlin: Springer 2000: 33-58
2 Kuni C C, Klingensmith W C. Focal nodular hyperplasia in Budd-Chiari syndrome. In: Kuni CC, Klingensmith WC, eds. Atlas of Radionuclide Hepatobilary Imaging Boston: G.K. Hall Medical Publishers 1983: 56-57
3 Piers D, Houthoff H, Krom R. Hot spot liver scan in focal nodular hyperplasia. Am J Roentgenol . 1980; 135 1289-1292
4 Lubbers P, Ros P, Goodman Z, Ishak K. Accumulation of technetium-99m sulfur colloid by hepatocellular adenoma: scintigraphic-pathologic correlation. Am J Roentgenol . 1987; 148 1105-1108
5 Kinnard M, Alavi A, Rubin R, Lichenstein G. Nuclear imaging of solid hepatic masses. Semin Roentgenol . 1995; 30 375-395
6 Rogers J, Mack L, Freeny P, Johnson M, Sones P. Hepatic focal nodular hyperplasia: angiography, CT, sonography, and scintigraphy. Am J Roentgenol . 1981; 137 983-990
7 Welch T, Sheedy P, Johnson C. Focal nodular hyperplasia and hepatic adenoma: comparison of angiography, CT, US, and scintigraphy. Radiology . 1985; 156 593-595
8 Kudo M, Ikekubo K, Yamamoto K. Distinction between hemangioma of the liver and hepatocellular carcinoma: value of labeled RBC-SPECT scanning. Am J Roentgenol . 1989; 152 977-983
9 Nelson R C, Chezmar J L. Diagnostic approach to hepatic hemangiomas. Radiology . 1990; 176 11-13
10 Birnbaum B, Weinreb J, Megibow A. Definitive diagnosis of hepatic hemangiomas: MR imaging versus Tc-99m-labeled red blood cell SPECT. Radiology . 1990; 176 95-101
11 Sostre S, Villagra D, Morales N, Rivera J. Dual-tracer scintigraphy and subtraction studies in the diagnosis of hepatocellular carcinoma. Cancer . 1988; 61 667-672
12 Serafini A, Jeffers L, Reddy K, Heiba S, Schiff E. Early recognition of recurrent hepatocellular carcinoma utilizing gallium-67 citrate scintigraphy. J Nucl Med . 1988; 29 712-716
13 Fonseca C, Greenberg D, Rosenthall L, Arzoumanian A. Assessment of the utility of gallbladder imaging with 99m-Tc-IDA. Clin Nucl Med . 1978; 3 437-441
14 Freitas J, Gulati M. Rapid evaluation of acute abdominal pain by hepatobiliary scanning. JAMA . 1980; 244 1585-1587
15 Krishnamurthy G, Krishnamurthy S. Acute cholecystitis. In: Nuclear Hepatology: A Textbook of Hepatobiliary Diseases Berlin: Springer 2000: 211-225
16 Matolo N, Stadalnik R, Dixon S. Value and limitations of scanning of the biliary tract. Surg Gynecol Obstet . 1980; 150 521-524
17 Mauro M, McCartney W, Melmud J. Hepatobiliary scanning with 99m-Tc-PIPIDA in acute cholecystitis. Radiology . 1982; 142 193-197
18 Szlabick R, Catto J, Fink-Bennett D, Ventura V. Hepatobiliary scanning in the diagnosis of acute cholecystitis. Arch Surg . 1980; 115 540-544
19 Weissmann H, Badia J, Sugarman L. Spectrum of 99m-Tc-IDA cholescintigraphic patterns in acute cholecystitis. Radiology . 1981; 138 167-175
20 Choy D, Shi E, McLean R. Cholescintigraphy in acute cholecystitis: use of intravenous morphine. Radiology . 1984; 151 203-307
21 Fig L, Stewart R, Wahl R, Shapiro B. Potential pitfalls in the use of morphine hepatobiliary scintigraphy. J Nucl Med (Abst). 1989; 30 850
22 Keslar P, Turbiner E. Hepatobiliary imaging and the use of intravenous morphine. Clin Nucl Med . 1987; 12 592-596
23 Kim E, Pjura G, Lowry P, Nguyen M, Pollack M. Morphine-augmented cholescintigraphy in the diagnosis of acute cholecystitis. Am J Roentgenol . 1986; 147 1177-1179
24 Kim C, Tse K, Juweid M, Mozley P, Woda A, Alavi A. Cholescintigraphy in the diagnosis of acute cholecystitis: morphine augmentation is superior to delayed imaging. J Nucl Med . 1993; 34 1866-1870
25 Kistler A, Ziessman H, Gooch D, Bitterman P. Morphone-augmented cholescintigraphy in acute cholecystitis: a satisfactory alternative to delayed imaging. Clin Nucl Med . 1991; 16 404-406
26 Fink-Bennett D, Balon H, Robbins T, Tsai D. Morphine-augmented cholescintigraphy: its efficacy in detecting acute cholecystitis. J Nucl Med (Abst) . 1989; 30 850
27 Mehta A, Alazraki N. The effectiveness of morphine in expediting the radionuclide diagnosis of acute cholecystitis. J Nucl Med (Abst). 1987; 28 596
28 Vasquez T, Greenspan G, Evans D, Halpern S, Ashburn W. Clinical efficacy of intravenous morphine administration in hepatobiliary imaging for acute cholecystitis. Clin Nucl Med . 1988; 13 4-6
29 Cabana M, Alavi A, Berlin J. Morphine-augmented hepatobiliary scintigraphy: a meta-analysis. Nucl Med Commun . 1995; 16 1068-1071
30 Samuels B, Freitas J, Bree R, Schwab R, Heller S. A comparison of radionuclide hepatobiliary imaging and real-time ultrasound for the detection of acute cholecystitis. Radiology . 1983; 147 207-210
31 Shea J, Berlin J, Escarce J. Revised estimates of diagnostic test sensitivity and specificity in suspected biliary tract disease. Arch Intern Med . 1994; 154 2573-2581
32 Kurtz A, Middleton W. Gallbladder. In: Kurtz A, Middleton W, eds. Ultrasound: The Requisites St. Louis: Mosby-Year Book 1996: 35-54
33 Shuman W, Rogers J, Rudd T. Low sensitivity of sonography and cholescintigraphy in acalculous cholecystitis. Am J Roentgenol . 1984; 142 531-534
34 Mirvis S, Vainright J, Nelson A. The diagnosis of acute acalculous cholecystitis: a comparison of sonography, scintigraphy, and CT. Am J Roentgenol . 1986; 147 1171-1175
35 Prevot N, Mariat G, Mahul P. Contribution of cholescintigraphy to the early diagnosis of acute acalculous cholecystitis in intensive-care-unit patients. Eur J Nucl Med . 1999; 26 1317-1325
36 Ramanna L, Brachman M, Tanasescu D, Berman D, Waxman A. Cholescintigraphy in acute acalculous cholecystitis. Am J Gastroenterol . 1984; 79 650-653
37 Swayne L. Acute acalculous cholecystitis: sensitivity in detection using technetium-99m iminodiacetic acid cholescintigraphy. Radiology . 1986; 160 33-38
38 Weissmann H, Berkowitz D, Fox M. The role of technetium-99m imunodiacetic acid (IDA) cholescintigraphy in acute acalculous cholecystitis. Radiology . 1983; 146 177-180
39 Krishnamurthy G, Krishnamurthy S. Biliary dyskinesia. In: Krishnamurthy G, Krishnamurthy S, eds. Nuclear Hepatology: A Textbook of Hepatobiliary Diseases Berlin: Springer 2000: 235-245
40 Ziessman H. Diagnosis of chronic acalculous cholecystitis using cholecystokinin cholescintigraphy: methodology and interpretation. In: Freeman L, ed. Nuclear Medicine Annual Philadelphia: Lippincott Williams & Wilkins 1999: 99-119
41 Krishnamurthy G, Krishnamurthy S. Cystic duct syndrome (chronic acalculous cholecystitis). In: Nuclear Hepatology: A Textbook of Hepatobiliary Diseases Berlin: Springer; 2000: 199-210
42 Fink-Bennett D, DeRidder P, Kolozsi W. Cholecystokinin cholescintigraphy: detection of abnormal gallbladder motor function in patients with chronic acalculous gallbladder disease. J Nucl Med . 1991; 32 1695-1699
43 Yap L, Wycherley A, Morphett A, Toouli J. Acalculous biliary pain: cholecystectomy alleviates symptoms in patients with abnormal cholescintigraphy. Gastroenterology . 1991; 101 786-793
44 Toper T, Tyerson T, Nora P. Quantitative gallbladder imaging following cholecyostokinin. J Nucl Med . 1980; 21 694-696
45 Pickelman J, Peiss R, Henkin R. The role of sincalide cholescintigraphy in the evaluation of patients with acalculous gallbladder disease. Arch Surg . 1985; 120 693-697
46 Zech E, Simmons L, Kendrick R. Cholecystokinin enhanced hepatobiliary scanning with ejection fraction calculation as an indicator of disease of the gallbladder. Surg Gynecol Obstet . 1991; 172 2124-2126
47 Reed D, Fernandez M, Hicks R. Kinevac-assisted cholescintigraphy as an accurate predictor of chronic acalculous gallbladder disease and the likelihood of symptom relief with cholecystectomy. Am J Surg . 1993; 59 273-277
48 Mishkind M, Pruitt R, Bambini D. Effectiveness of cholecystokinin-cholescintigraphy in the diagnosis and treatment of acalculous gallbladder disease. Ann Surg . 1997; 63 769-774
49 Sorenson M, Fancer S, Lang N. Abnormal gallbladder nuclear ejection fraction predicts success of cholecystectomy in patients with biliary dyskinesia. Am J Surg . 1993; 166 672-674
50 Middleton G, Williams J. Is gallbladder ejection fraction a reliable predictor of acalculous gallbladder disease?. Nucl Med Commun . 1992; 13 894-896
51 Halverson J, Garner B, Siegel B. The use of hepatobiliary scintigraphy in patients with acalculous biliary colic. Arch Intern Med . 1992; 152 1305-1307
52 Ziessman H. Cholecystokinin cholescintigraphy: victim of its own success?. J Nucl Med . 1999; 40 2038-2042
53 Krishnamurthy S, Krishnamurthy G. Biliary dyskinesia: role of the sphincter of Oddi, gallbladder and cholecystokinin. J Nucl Med . 1997; 38 1824-1830
54 Dodds W, Thakur S, Collier R. Quantitative hepatobiliary scintigraphy. J Nucl Med . 1990; 31 1468-1469
55 Fullarton G, Hilditch T, Campbell A, Murray W. Clinical and scintigraphic assessment of the role of endoscopic sphinterotomy in the treatment of sphincter of Oddi dysfunction. Gut . 1990; 31 231-235
56 Shaffer E, Hershfield N, Logan K, Kloiber R. Cholescintigraphic detection of functional obstruction of the sphincter of Oddi: effect of papillotomy. Gastroenterology . 1986; 90 728-733
57 Cicala M, Scopinaro F, Corzziari E. Quantitative cholescintigraphy in the assessment of choledochoduodenal bile flow. Gastroenterology . 1991; 100 1106-1113
58 Madacsy L, Velosy B, Lonovics J, Csernay L. Differentiation between organic and functional dyskinesia of the sphincter of Oddi with amyl nitrate-augmented quantitative hepatobiliary scintigraphy. Eur J Nucl Med . 1994; 21 203-208
59 Sostre S, Kalloo A, Spiegler E, Camargo E, Wagner Jr H. A noninvasive test of sphincter of Oddi dysfunction in postcholecystectomy patients: the scintigraphic score. J Nucl Med . 1992; 33 1216-1222
60 Kalloo A, Sostre S, Meyerrose G, Pasricha P, Szabo Z. Gallbladder ejection fraction: nondiagnostic for sphincter of Oddi dysfunction in patients with intact gallbladders. Clin Nucl Med . 1994; 19(8) 713-719
61 Ruffolo T, Sherman S, Lehman G, Hawes R. Gallbladder ejection fraction and its relationship to sphincter of Oddi dysfunction. Dig Dis Sci . 1994; 39 289-292
62 Bar-Meir S, Chamovitz D. 99mTc-DISIDA versus endoscopic biliary manometry in assessing sphincter of Oddi function. Hepatology . 1989; 10 895-896
63 Lee R, Gregg J, Koroshetz A, Hill T, Clouse M. Sphincter of Oddi stenosis: diagnosis using hepatobiliary scintigraphy and endoscopic manometry. Radiology . 1985; 156 793-796
64 Krishnamurthy G, Krishnamurthy S. Extrahepatic cholestasis. In: Krishnamurthy G, Krishnamurthy S, eds. Nuclear Hepatology: A Textbook of Hepatobiliary Diseases.Berlin: Springer; 2000: 159-187
65 Klingensmith W C, Kuni C C, Fritzberg A R. Cholescintigraphy in extrahepatic biliary obstruction. Am J Roentgenol . 1982; 139 65-70
66 Kuni C C, Klingensmith W C, Fritzberg A R. Evaluation of intrahepatic cholestasis with Tc-99m-labeled radiopharmaceuticals. Gastrointest Radiol . 1984; 9 163-166
67 Larar G N, Tumeh S. Intrahepatic versus extrahepatic cholestasis in hepatobiliary scintigraphy. J Nucl Med . 1992; 33 1186-1190
68 Brugge W, Alavi A. Cholescintigraphy in the diagnosis of the complications of laparoscopic cholecystectomy. Semin Ultrasound CT MR . 1993; 14 368-374
69 Weissmann H, Gliedman M, Wilk P. Evaluation of the postoperative patient with 99m-Tc-IDA cholescintigraphy. Semin Nucl Med . 1982; 12 27-52
70 Rayter Z, Tonge C, Bennett C, Thomas M, Robinson P. Ultrasound and HIDA: scanning in evaluating bile leaks after cholecystectomy. Nucl Med Commun . 1991; 12 197-202
71 Brugge W, Rosenberg D, Alavi A. Diagnosis of postoperative bile leaks. Am J Gastroenterol . 1994; 89 2178-2183
72 Walker A, Shapiro A, Brooks D, Braver J, Tumeh S. Bile duct disruption and biloma after laparoscopic cholecystectomy: imaging evaluation. Am J Roentgenol . 1992; 158 785-789
73 Sandoval B, Goettler C, Robinson A, O'Donnell J, Adler L, Stellato T. Cholescintigraphy in the diagnosis of bile leak after laparoscopic cholecystectomy. Am Surg . 1997; 63 611-616
74 Estrada W, Zanzi I, Ward R, Negrin J, Margouleff D. Scintigraphic evaluation of postoperative complications of laparoscopic cholecystectomy. J Nucl Med . 1991; 32 1910-1911
75 Peters J, Ollila D, Nichols K. Diagnosis and management of bile leaks following laparoscopic cholecystectomy. Surg Laparosc Endosc . 1994; 4 163-170
76 Scott-Smith W, Raftery A, Wraight E, Calne R. Tc-99m labeled HIDA imaging in suspected biliary leaks after liver transplantation. Clin Nucl Med . 1983; 8 478-479
77 Kurzawinski T, Selves L, Farouk M. Prospective study of hepatobiliary scintigraphy and endoscopic cholangiography for the detection of early biliary complications after orthotopic liver transplantation. Br J Surg . 1997; 84 620-623
78 Anselmi M, Lancberg S, Deakin M. Assessment of the biliary tract after liver transplantation: T tube cholangiography or IODIDA scanning. Br J Surg . 1990; 77 1233-1237
79 Lantsberg S, Lanchbury E, Drolc Z. Evaluation of bile duct complications after orthotopic liver transplantation by hepatobiliary scanning. Nucl Med Commun . 1990; 11 761-769
80 Banzo I, Blanco I, Gutierrez-Mendiguchia C. Hepatobiliary scintigraphy for the diagnosis of bile leaks produced after T-tube removal in orthotopic liver transplantation. Nucl Med Commun . 1998; 19 229-236
81 Mochizuki T, Tauxe W, Dobkin J. Detection of complications after liver transplantation by technetium-99m mebrofenin hepatobiliary scintigraphy. Ann Nucl Med . 1991; 5 103-107
82 Von Moll L, Juni J, Merion R. Scintigraphic demonstration of accessory hepatic duct leak following liver transplantation. J Nucl Med . 1988; 29 259-262
83 Gilsdorf J, Phillips M, McLeod M. Radionuclide evaluation of bile leakage and the use of subhepatic drains after cholecystectomy. Am J Surg . 1986; 151 259-262
84 Frakes J, Bradley S. Endoscopic stent placement for biliary leak from an accessory duct of Luschka after laparoscopic cholecystectomy. Gastrointest Endosc . 1993; 39 90-92
85 Ralph-Edwards T, Himal H. Bile leak after laparoscopic cholecystectomy. Surg Endosc . 1992; 6 33-35
86 Jenkins M, Ponsky J, Lehman G. Treatment of bile leaks from the cystohepatic ducts after laparoscopic cholecystectomy. Surg Endosc . 1994; 8 193-196
87 Kuni C. Scintigraphy in liver transplants. In: Letourneau J, Day D, Ascher N, eds. Radiology of Organ Transplantation St. Louis: Mosby-Year Book 1991: 170-178
88 Kuni C, Engeler C, Nakhleh R, duCret R, Boudreau R. Correlation of technetium-99m-DISIDA hepatobiliary studies with biopsies in liver transplant patients. J Nucl Med . 1991; 32 1545-1547
89 Engeler C, Kuni C, Nakhleh R, Engeler C, duCret R, Boudreau R. Liver transplant rejection and cholestasis: comparison of technetium 99m-diisopropyl iminodiacetic acid hepatobiliary imaging with liver biopsy. Eur J Nucl Med . 1992; 19 865-870
90 Brunot B, Petras S, Germain P, Vinee P, Constantinesco A. Biopsy and quantitative hepatobiliary scintigraphy in the evaluation of liver transplantation. J Nucl Med . 1994; 35 1321-1327
91 Loken M, Ascher N, Boudreau R, Najarian J. Scintigraphic evaluation of liver transplant function. J Nucl Med . 1986; 27 451-459
92 Hawkins R, Hall T, Gambhir S. Radionuclide evaluation of liver transplants. Semin Nucl Med . 1988; 18 199-212
93 Ekman M, Fjalling M, Friman S, Carlson S, Volkmann R. Liver uptake function measured by IODIDA clearance rate in liver transplant patients and healthy volunteers. Nucl Med Commun . 1996; 17 235-242
94 Shah A, Dodson F, Fung J. Role of nuclear medicine in liver transplantation. Semin Nucl Med . 1995; 25 36-48
95 Williams H, Pope C, Siskind B, Lange R, Flye M. Vascular thrombosis in acute hepatic allograft-rejection: scintigraphic appearance. J Nucl Med . 1985; 26 478-481
96 Dalen K, Day D, Ascher N. Imaging of vascular complications after hepatic transplantation. Am J Roentgenol . 1988; 150 1285-1290
97 Brown R, Memsic L, Busuttil R. Accurate demonstration of hepatic infarction in liver transplant recipients. J Nucl Med . 1986; 27 1428-1431
98 Gelfand M, Smith H, Ryckman F. Hepatobiliary scintigraphy in pediatric liver transplant recipients. Clin Nucl Med . 1992; 17 542-549
99 Krishnamurthy G, Krishnamurthy S. Congenital biliary atresia. In: Krishnamurthy G, Krishamurthy S, eds. Nuclear Hepatology: A Textbook of Hepatobiliary Diseases Berlin: Springer; 2000: 250-268
100 Majd M, Reba R, Altman R. Hepatobiliary scintigraphy with 99mTc-PIPIDA in the evaluation of neonatal jaundice. Pediatrics . 1981; 67 140-145
101 Gerhold J, Klingensmith W R, Kuni C. Diagnosis of biliary atresia with radionuclide hepatobiliary imaging. Radiology . 1983; 146 499-504
102 Manolaki A, Larcher V, Mowat A. The prelaparotomy diagnosis of extrahepatic biliary atresia. Arch Dis Child . 1983; 58 591-594
103 Tolia V, Dubois R, Kagalwalla A. Comparison of radionuclear scintigraphy and liver biopsy in the evaluation of neonatal cholestatis. J Pediatr Gastroenterol Nutr . 1986; 5 30-45
104 Spivak W, Sarkar S, Winter D. Diagnostic utility of hepatobiliary scintigraphy with 99mTc-DISIDA in neonatal cholestasis. J Pediatr . 1987; 110 855-861
105 Park W, Choi S, Lee H. A new diagnostic approach to biliary atresia with emphasis on the ultrasonographic triangular cord sign: comparison of ultrasonography, hepatobiliary scintigraphy, and liver needle biopsy in the evaluation of infantile cholestasis. J Pediatr Surg . 1997; 32 1555-1559
106 Majd M, Reba R, Altman R. Effect of phenobarbital on 99mTc-IDA scintigraphy in the evaluation of neonatal jaundice. Semin Nucl Med . 1981; 11 194-204
107 Cox K, Stadalnik R, McGahan J. Hepatobiliary scintigraphy with technetium-99m disofenin in the evaluation of neonatal cholestasis. J Pediatr Gastroenterol Nutr . 1987; 6 885-891
108 Gilmour S, Hershkop M, Reifen R, Gilday D, Roberts E. Outcome of hepatobiliary scanning in neonatal hepatitis syndrome. J Nucl Med . 1997; 38 1279-1282
109 Johnson K, Alton H, Chapman S. Evaluation of mebrofenin hepatoscintigraphy in neonatal-onset jaundice. Pediatr Radiol . 1998; 28 937-941
110 Ben-Haim S, Seabold J, Kao S, Johnson J, Tran D, Brown B. Utility of Tc-99m mebrofenin scintigraphy in the assessment of infantile jaundice. Clin Nucl Med . 1995; 20 153-163
111 Summerville D, Marks M, Treves S. Hepatobiliary scinitgraphy in arteriohepatic dysplasia (Alagille's syndrome): a report of two cases. Pediatr Radiol . 1988; 18 32-40
112 Lin W, Lin C, Changlai S, Shen Y, Wang S. Comparison technetium of Tc-99m disofenin cholescintigraphy with ultrasonography in the differentiation of biliary atresia from other forms of neonatal jaundice. Pediatr Surg Int . 1997; 12 30-33
113 Abramson S, Treves S, Teele R. The infant with possible biliary atresia: evaluation of ultrasound and nuclear medicine. Pediatr Radiol . 1982; 12 1-5
114 Delbeke D. Oncological applications of FDG PET imaging brain tumors, colorectal cancer lymphoma and melanoma. J Nucl Med . 1999; 40 591-603
115 Hustinx R, Paulus P, Jacquet N. Clinical evaluation of whole-body 18F-fluorodeoxyglucose positron emission tomography in the detection of liver metastases. Ann Oncol . 1998; 9 397-401
116 Delbeke D, Vitola J, Sandler M. Staging recurrent metastatic colorectal carcinoma with PET. J Nucl Med . 1997; 38 1196-1201
117 Boykin K, Zibari G, Lilien D. The use of FDG-positron emission tomography for the evaluation of colorectal metastases of the liver. Am Surg . 1999; 65 1183-1185
118 Vitola J, Delbeke D, Sandler M. Positron emission tomography to stage suspected metastatic colorectal carcinoma to the liver. Am J Surg . 1996; 171 21-26
119 Lai D, Fulham M, Stephen M. The role of whole-body positron emission tomography with [18F] fluorodeoxyglucose in identifying operable colorectal cancer metastases to the liver. Arch Surg . 1996; 131 703-707
120 Frohlich A, Diederichs C, Staib L. Detection of liver metastases from pancreatic cancer using FDG PET. J Nucl Med . 1999; 40 250-255
121 Nakamoto Y, Higashi T, Sakahara H. Contribution of PET in the detection of liver metastases from pancreatic tumours. Clin Radiol . 1999; 54 248-252
122 Trojan J, Schroeder O, Raedle J. Fluorine-18 FDG positron emission tomography fopr imaging of hepatocellular carcinoma. Am J Gastroenterol . 1999; 94 3314-3319
123 Delbeke D, Martin W, Sandler M. Evaluation of benign versus malignant hepatic lesions with positron emission tomography. Arch Surg . 1998; 133 510-516
124 Khan M, Combs C, Brunt E. Positron emission tomography scanning in the evaluation of hepatocellular carcinoma. J Hepatology . 2000; 32 792-797
125 Schroder O, Trojan J, Zeuzem S, Baum R. Limited value of fluorine-18-fluorodeoxyglucose PET for the differential diagnosis of focal liver lesions in patients with chronic hepatitis C virus infection. Nuklearmedizin . 1998; 37 279-285
126 Nagata Y, Yamamoto K, Hiraoka M. Monitoring liver tumor therapy with [18F] FDG positron emission tomography. J Comput Assist Tomogr . 1990; 14 370-374
127 Okazumi S, Isono K, Enomoto K. Evaluation of liver tumors using fluorine-18-fluorodeoxyglucose PET: characterization of tumor and assessment of effect of treatment. J Nucl Med . 1992; 33 333-339
128 Torizuka T, Tamaki N, Inokuma T. In vivo assessent of glucose metabolism in hepatocellular carcinoma with FDG-PET. J Nucl Med . 1995; 36 1811-1817
129 Keiding S, Hansen S, Rasmussen H. Detection of cholangiocarcinoma in primary sclerosing cholangitis by positron emission tomography. Hepatology . 1998; 28 700-706
130 Iwata Y, Shiomi S, Sasaki N. Clinical usefulness of positron emission tomography with fluorine-18-fluorodeoxyglucose in the diagnosis of liver tumors. Ann Nucl Med . 2000; 14 121-126
131 Findlay M, Young H, Cunningham D. Noninvasive monitoring of tumor metabolism using fluorodeoxyglucose and positron emission tomography in colorectal cancer liver metastases: correlation with tumor response to fluorouracil. J Clin Oncol . 1996; 14 700-708
132 Dimitrakopoulou A, Strauss L, Clorius J. Studies with positron emission tomography after systemic administration of fluorine-18-uracil in patients with liver metastases from colorectal carcinoma. J Nucl Med . 1993; 34 1075-1081
133 Dimitrakopoulou-Strauss A, Strauss L, Schlag P. Fluorine-18-fluorouracil to predict therapy response in liver metastases from colorectal carcinoma. J Nucl Med . 1998; 39 1197-1202
134 Moehler M, Dimitrakopoulou-Strauss A, Gutzler F. 18F-labeled fluorouracil positron emission tomography and the prognoses of colorectal carcinoma patients with metastases to the liver treated with 5-fluorouracil. Cancer . 1998; 83 245-253
135 Torizuka T, Tamaki N, Inokuma T. Value of fluorine-18-FDG-PET to monitor hepatocellular carcinoma after interventional therapy. J Nucl Med . 1994; 35 1965-1969
136 Vitola J, Delbeke D, Meranze S, Mazer M, Pinson C. Positron emission tomography with F-18-fluorodeoxyglucose to evaluate the results of hepatic chemoembolism. Cancer . 1996; 78 2216-2222